Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06096194
Other study ID # FM/DI/0282018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 15, 2018
Est. completion date December 21, 2019

Study information

Verified date October 2023
Source Instituto Nacional de Salud Publica, Mexico
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is double-blind, controlled fiel trial, to compare fortified egg with D3-or 25(OH)D3 and non-fortified eggs in healthy preschool-age children 12 to 60 months of age, affiliated to day-care centers at Secretaria de Desarrollo Social (SEDESOL). The study aims to answer are: 1. to evaluate the efficacy of fortified egg with vitamian D3 on serum concentrations of 25-hydroxyvitamin D3 2. and to evaluate parathyroid hormone (PTH) in children aged 12 to 60 months of age. - Children would be given for breakfast fortified egg/non-foritfied egg three times per week for 12 weeks. - Blood samples will be taken at baseline and at the end of study. - Anthropometric meassurements weight /height will be taken at baseline and at end of study.


Description:

1. Vitamin D functions: Vitamin D (VD) is a fat-soluble vitamin. Its main function is to maintain optimal levels of calcium and phosphorus in the body; it also helps in neuromuscular transmission and bone mineralization, important in bone health and growth in children. There are VD receptors in bone, bone marrow, adipose tissue, adrenal, brain, stomach, small intestine, colon, pancreas, liver, lung, muscle, activated B and T lymphocytes, and in other organs, tissues, and cells. For this reason, various functions are assumed. VD serum concentrations above 75 mmol/l (30 ng/ml) have been shown to keep cell growth under control and prevent cells from becoming autonomous and malignant. 2. Prevalences of vitamin D deficiencies and insufficiency: Worldwide, a high proportion of children, youth, and middle-aged adults are deficient in Vitamin D. It has been estimated that about one billion people in the world may be deficient in Vitamin D. In Latin America, only Mexico has representative population data on vitamin D deficiency. Recently it has been documented that the deficiency and insufficiency of Vitamin D are a public health problem in Mexico. In a national representative sample of 6,827 children aged 1 to 11 years who participated in the 2012 National Health and Nutrition Survey (ENSANUT), the prevalence of Vitamin D deficiency was 33% (25-OH-D <50 nmol/L), which means that there are 3 million children with Vitamin D deficiency in Mexico. On the other hand, insufficiency (25-OH-D of 50 <75 nmol/L) affects 56% of children. Likewise, it was found that less than 3% of children consume a supplement with Vitamin D. 3. Vitamin D intake recommendations in children: The current vitamin D intake recommendations made by the APP since 2008 (Wagner CL, 2008) for children aged 1 to 8 years is an Adequate Intake of 400-600 IU (10-15µg), and for the Tolerable Upper Intake Level it is suggested do not exceed 2500 IU (63µg) in the case of children from 1 to 3 years and 3000 IU (75µg) in children from 4 to 8 years. 4. Description of the study: A double-blind controlled cluster randomized field trial was developed. The participants were children from 6 day-care centers (SEDESOL) at Cuernavaca, Morelos, Mexico. The study sample had 275 children that completed the study (the protocol considered having at least 125 children in each treatment group), from 12 to 59 months, who attended 6 take care centers (SEDESOL), in Cuernavaca, Morelos. 5. Objective To evaluate the efficacy of the consumption of fortified eggs with Vitamin D3 on the serum concentrations of 25-OH-D in children aged 12 to 59 months who attend take care centers (SEDESOL)in Cuernavaca. 6. Treatment and control groups: The random assignments of the intervention group (fortified egg) and control group (unfortified egg) were done considering each day-care center as a unit of allocation. Three day-care centers were randomized to the intervention group and three to the control group. The study lasted 12 weeks. The treatment group consumed a fortified egg to provide 10 mcg of Vitamin D3 equivalent to 400 IU of Cholecalciferol, 3 times a week. The control group received unfortified egg (~ 43 IU Vitamin D) with the same frequency as the intervention group. 7. Main Outcomes: The main outcome outcome variables were the serum levels of 25-hydroxyvitamin D3 (25-OH-D3) The second main outcome was to evaluate the parathyroid hormone (PTH). Other Variables: Blood parameters were taken: total cholesterol, HDL cholesterol, triglycerides, glucose, and hemoglobin. Anthropometric measurements of weight, height, age. Morbidity (diarrhea, constipation and respiratory tract infections) was evaluated three times per week and recorded. Standardized personnel weight the egg consumed before and after breakfast with a food weighing scale. Mothers were asked about children's usual diet by two diet questionnaires : a 24-hour dietary recall and a food frequency questionnaire at baseline and at the end of the study. 8. Ethical considerations: The protocol was submitted to he Research and Ethics Committee of the Medicine Research Division of the National Autonomous University of Mexico.The study was approved on May 8, 2018 with folio FM/DI/028/2018. The children's mothers or guardians signed an informed consent letter.


Recruitment information / eligibility

Status Completed
Enrollment 275
Est. completion date December 21, 2019
Est. primary completion date November 30, 2018
Accepts healthy volunteers No
Gender All
Age group 12 Months to 59 Months
Eligibility Inclusion Criteria: - Children of either sex, from 12 to 59 months of age who attend take care SEDESOL centers - Children who consume eggs within their usual diet at least 5 times per month - Childrens whose parents or legal guardian agree to participate in the study and sign an informed consent letter Exclusion Criteria: - Children with an egg allergy - Chldren with hypersensitivity to vitamin D - Children who have taken vitamin D supplements in the past month

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
vitamin D-enhanced egg
In our study, the vitamin D3-enhanced eggs were produced by hens that received 23,500 IU of vitamin D3 per kg of feed. Which does not confer them any harm or danger of intoxication. This experiment was carried out at the Center for Teaching, Research and Extension in Poultry Production (CEIEPAv, FMVZ-UNAM) and lasted 40 weeks. This ensured that the hens eggs were enhanced with vitamin D achieving a final concentration of approximately 400 IU of vitamin D
Other:
Control
Unfortified eggs were used for the control group with a concentration of approximately 43 IU of vitamin D

Locations

Country Name City State
Mexico Instituto Nacional de Salud Pública Cuernavaca Morelos

Sponsors (2)

Lead Sponsor Collaborator
Instituto Nacional de Salud Publica, Mexico DSM Nutritional Products, Inc.

Country where clinical trial is conducted

Mexico, 

Outcome

Type Measure Description Time frame Safety issue
Other Insulin ug/dL At baseline and at 12 weeks of intervention
Other Weight kg At baseline and at 12 weeks of intervention
Other Height cm At baseline and at 12 weeks of intervention
Other Total Cholesterol mg/dL At baseline and at 12 weeks of intervention
Other Triglicerids mg/dL At baseline and at 12 weeks of intervention
Other HDLc mg/dL At baseline and at 12 weeks of intervention
Other Glucose mg/dL At baseline and at 12 weeks of intervention
Primary Serum 25-OH-D nmol/L At baseline and at 12 weeks of intervention
Secondary Serum PTH pcg/mL At baseline and at 12 weeks of intervention
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04244474 - Effect of Vitamin D Supplementation on Improvement of Pneumonic Children Phase 1/Phase 2
Recruiting NCT05459298 - ViDES Trial (Vitamin D Extra Supplementation) N/A
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT04476511 - The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules Phase 3
Completed NCT03920150 - Vitamin D 24'000 IU for Oral Intermittent Supplementation Phase 3
Completed NCT03264625 - The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis Phase 2
Completed NCT04183257 - Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics Phase 4
Recruiting NCT05084248 - Vitamin D Deficiency in Adults Following a Major Burn Injury Phase 4
Completed NCT05506696 - Vitamin D Supplementation Study N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Completed NCT03234218 - Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study
Completed NCT02906319 - Vitamin D and HbA1c Levels in Diabetic Patients With CKD N/A
Completed NCT03203382 - Corneal Nerve Structure in Sjogren's
Completed NCT02714361 - A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women N/A
Completed NCT02118129 - Vitamin D Among Young Adults: an Intervention Study Using a Mobile 'App'. N/A
Not yet recruiting NCT01419821 - Vitamin D and Its Affect on Growth Rates and Bone Mineral Density Until Age 5 N/A
Completed NCT02275650 - The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter N/A
Completed NCT02187146 - The Effects of Serum Vitamin D and IVF Outcome N/A
Completed NCT01688102 - The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile N/A
Completed NCT01651000 - Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency Phase 3